Supportive care in hematologic malignancies.
Curr Opin Hematol
; 5(4): 271-86, 1998 Jul.
Article
en En
| MEDLINE
| ID: mdl-9747634
ABSTRACT
Supportive care in hematologic malignancies includes a wide range of topics. We have selected the following issues for a review of recently published developments new insights into the benefits and risks of established hematopoietic growth factors (HGF), such as granulocyte- or granulocyte-macrophage colony-stimulating factor (G-CSF, GM-CSF); the emerging role of newly introduced HGFs such as keratinocyte-growth factor (KGF) and thrombopoietin; the prophylactic and therapeutic use of amifostine, a cytoprotective agent; the role of hematopoietic growth factors and the demethylating agent decitabine in myelodysplastic syndromes (MDS); infectious complications of anticancer therapy; and, recent improvements in and complications of transfusional therapy, including the renewed interest in granulocyte transfusions.
Buscar en Google
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Hematológicas
Tipo de estudio:
Etiology_studies
Idioma:
En
Revista:
Curr Opin Hematol
Asunto de la revista:
HEMATOLOGIA
Año:
1998
Tipo del documento:
Article